Travere Therapeutics
TVTX
TVTX
133 hedge funds and large institutions have $719M invested in Travere Therapeutics in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 60 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
133
Holders Change
+7
Holders Change %
+5.56%
% of All Funds
3.72%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.17%
New
25
Increased
60
Reduced
39
Closed
17
Calls
$76.4M
Puts
$32.6M
Net Calls
+$43.8M
Net Calls Change
+$5.07M
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$13.5M |
| 2 |
SAM
Senzar Asset Management
New York
|
+$10.4M |
| 3 |
Goldman Sachs
New York
|
+$9.87M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$9.83M |
| 5 |
BC
Broadfin Capital
New York
|
+$9.05M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$14M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$7.56M |
| 3 |
Millennium Management
New York
|
-$7.44M |
| 4 |
WSA
Wall Street Associates
Lajolla,
California
|
-$4.8M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$3.69M |
